SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-057269
Filing Date
2015-08-06
Accepted
2015-08-06 17:20:56
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-11873_110q.htm 10-Q 660866
2 EX-10.2 a15-11873_1ex10d2.htm EX-10.2 80869
3 EX-31.1 a15-11873_1ex31d1.htm EX-31.1 11198
4 EX-32.1 a15-11873_1ex32d1.htm EX-32.1 5425
  Complete submission text file 0001104659-15-057269.txt   3179392

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT espr-20150630.xml EX-101.INS 645522
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20150630.xsd EX-101.SCH 24193
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20150630_cal.xml EX-101.CAL 36433
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT espr-20150630_lab.xml EX-101.LAB 275035
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20150630_pre.xml EX-101.PRE 176690
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20150630_def.xml EX-101.DEF 69716
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 151034243
SIC: 2834 Pharmaceutical Preparations